| 0.9 |
3.8 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.6 |
0.6 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.4 |
1.3 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.3 |
1.0 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.3 |
1.0 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.3 |
2.8 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.9 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.3 |
0.9 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.3 |
0.9 |
GO:0072096 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.3 |
0.8 |
GO:0033869 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.3 |
0.3 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.3 |
1.9 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 |
2.6 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 |
3.3 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.3 |
0.8 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
0.8 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 |
0.2 |
GO:0072003 |
kidney rudiment formation(GO:0072003) |
| 0.2 |
1.2 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.2 |
0.9 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 |
0.7 |
GO:0100009 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 |
0.9 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.2 |
0.6 |
GO:0031550 |
positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.2 |
1.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
0.6 |
GO:0071931 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 0.2 |
0.6 |
GO:0036510 |
trimming of terminal mannose on C branch(GO:0036510) |
| 0.2 |
2.5 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 |
0.2 |
GO:0090274 |
regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.2 |
0.2 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 |
0.3 |
GO:1900168 |
glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.2 |
0.5 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.2 |
0.9 |
GO:2000690 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 |
0.5 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
0.8 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
1.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
0.5 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
0.5 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
2.6 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.5 |
GO:0003129 |
heart induction(GO:0003129) |
| 0.2 |
0.2 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.2 |
0.5 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 |
0.8 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
1.2 |
GO:0044375 |
peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.6 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.6 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.6 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 |
0.8 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
0.6 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 |
1.6 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.3 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.4 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
0.4 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.4 |
GO:0006393 |
termination of mitochondrial transcription(GO:0006393) |
| 0.1 |
0.4 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.5 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 |
0.4 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.1 |
0.4 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
0.4 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 |
0.4 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.1 |
0.4 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
1.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.5 |
GO:1904045 |
cellular response to aldosterone(GO:1904045) |
| 0.1 |
0.4 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
0.6 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
3.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.4 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.7 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.6 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.4 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 0.1 |
0.3 |
GO:0045554 |
TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
0.4 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.2 |
GO:2000360 |
negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 |
0.4 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.1 |
2.8 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
0.2 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.4 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
2.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.3 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 |
0.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.6 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.6 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.7 |
GO:0003138 |
primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 |
0.7 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 |
0.3 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 0.1 |
0.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.9 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.1 |
0.5 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 |
0.3 |
GO:0099404 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.1 |
0.3 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 |
0.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
1.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.7 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.1 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
1.2 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 |
0.6 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.2 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 |
0.3 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) T-helper 1 cell cytokine production(GO:0035744) |
| 0.1 |
0.3 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.2 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.1 |
0.2 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.1 |
0.3 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.1 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.4 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.1 |
0.2 |
GO:1902958 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.1 |
0.6 |
GO:0070272 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.2 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.1 |
0.4 |
GO:0032803 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.1 |
0.5 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.5 |
GO:0086047 |
Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.1 |
0.2 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.1 |
0.5 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.2 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.1 |
0.4 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.4 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.1 |
0.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.3 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.2 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
2.5 |
GO:0061049 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:0016116 |
tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.1 |
0.5 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.6 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.3 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.3 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.3 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.2 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.1 |
0.2 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.1 |
0.3 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.2 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.4 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.1 |
GO:0006113 |
fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.1 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.3 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.4 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.8 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.2 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
0.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.4 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 |
0.7 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.4 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.1 |
0.4 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.1 |
0.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.3 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.4 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.6 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.4 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
0.5 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.2 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.1 |
0.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.3 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
0.4 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.1 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
0.3 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.1 |
0.3 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.1 |
0.1 |
GO:0002588 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
0.2 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
1.0 |
GO:0072663 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.2 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.3 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.2 |
GO:2000452 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.1 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.1 |
0.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.2 |
GO:0030472 |
mitotic spindle organization in nucleus(GO:0030472) |
| 0.1 |
0.3 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
0.3 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.2 |
GO:0046080 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 |
0.2 |
GO:0061187 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
1.2 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.0 |
0.3 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.0 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.1 |
GO:0061445 |
endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 0.0 |
0.2 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.2 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.0 |
0.2 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.0 |
0.1 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.0 |
0.2 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 |
0.4 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.1 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.0 |
0.0 |
GO:1903347 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.0 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.1 |
GO:0015847 |
putrescine transport(GO:0015847) |
| 0.0 |
0.1 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.0 |
0.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.4 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.1 |
GO:0010652 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.0 |
0.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 |
0.5 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.0 |
0.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.0 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.0 |
1.7 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
0.7 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.5 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.3 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
0.2 |
GO:1901594 |
detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.0 |
0.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.2 |
GO:0009305 |
protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.0 |
0.2 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.1 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 |
0.1 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.0 |
0.7 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.0 |
0.1 |
GO:0072007 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) |
| 0.0 |
0.6 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.2 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
1.0 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.0 |
0.1 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.0 |
0.5 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.2 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 |
1.3 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.0 |
0.8 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
1.6 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.2 |
GO:2000389 |
regulation of neutrophil extravasation(GO:2000389) |
| 0.0 |
0.2 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.1 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.0 |
0.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.0 |
0.4 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
1.0 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.2 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0007309 |
oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.0 |
0.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
1.0 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.3 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.0 |
0.1 |
GO:0002881 |
negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.1 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.2 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.0 |
0.1 |
GO:0034444 |
negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.0 |
0.1 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.0 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.1 |
GO:0098758 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.0 |
0.4 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.0 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.6 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.5 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.1 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 |
0.6 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.0 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.0 |
0.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.1 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 |
0.1 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.0 |
0.4 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.7 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
1.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.9 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.2 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.3 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 |
0.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.1 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.2 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.2 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 |
0.4 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.5 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.1 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.0 |
0.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.0 |
0.3 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.2 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.3 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.1 |
GO:0043091 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.0 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.0 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.0 |
0.1 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.3 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.0 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.2 |
GO:0045007 |
depurination(GO:0045007) |
| 0.0 |
0.1 |
GO:0034091 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.0 |
0.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.1 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.0 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.0 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.4 |
GO:0070071 |
proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.0 |
0.6 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.2 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.0 |
0.1 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.3 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.0 |
0.1 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.0 |
0.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.5 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.1 |
GO:0070476 |
RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.0 |
0.1 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.0 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 |
0.1 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 |
0.1 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.2 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.5 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.0 |
1.1 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.0 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.3 |
GO:1901678 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.0 |
0.3 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.1 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.0 |
0.0 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.1 |
GO:0035928 |
mitochondrial RNA 5'-end processing(GO:0000964) rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
0.6 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.3 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.1 |
GO:0015855 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.0 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.0 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.0 |
0.2 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.2 |
GO:0098907 |
protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.0 |
0.1 |
GO:0036048 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.0 |
0.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.0 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.1 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 |
0.1 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 |
0.1 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.0 |
0.2 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.0 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.0 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.1 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:0019878 |
lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.0 |
0.8 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 |
0.1 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.0 |
GO:0099553 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.0 |
0.1 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.0 |
0.0 |
GO:1900190 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.0 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.0 |
0.0 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.0 |
0.1 |
GO:1901377 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.1 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.0 |
0.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 0.0 |
0.3 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.1 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.0 |
0.1 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.0 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.5 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.0 |
GO:0048936 |
peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.0 |
0.1 |
GO:0002270 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.4 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 |
0.3 |
GO:0002251 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.3 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.0 |
1.2 |
GO:0090109 |
regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
| 0.0 |
0.4 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.2 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.0 |
0.2 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.2 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.0 |
0.6 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.1 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.5 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.2 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.0 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.0 |
0.3 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.0 |
0.4 |
GO:0060004 |
reflex(GO:0060004) |
| 0.0 |
0.3 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.1 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.2 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.2 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 |
0.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.1 |
GO:1902904 |
vacuolar transmembrane transport(GO:0034486) late endosomal microautophagy(GO:0061738) protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.0 |
0.3 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.5 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.2 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.1 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.1 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 |
0.5 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.7 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.1 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.0 |
0.1 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.0 |
0.1 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.0 |
GO:2001201 |
regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.0 |
0.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.1 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.0 |
0.1 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.0 |
0.1 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.0 |
0.2 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.0 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.0 |
0.2 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.2 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 |
0.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.0 |
0.0 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.0 |
0.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.0 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.0 |
0.1 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.1 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.2 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 |
0.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
0.0 |
GO:0003245 |
growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.0 |
0.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
0.3 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.1 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.1 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 |
0.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.0 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.2 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.4 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.1 |
GO:0015770 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.2 |
GO:1903209 |
cellular response to nitric oxide(GO:0071732) positive regulation of oxidative stress-induced cell death(GO:1903209) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.2 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.0 |
0.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.1 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 |
0.0 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.0 |
0.1 |
GO:1900409 |
positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
| 0.0 |
0.1 |
GO:2001205 |
negative regulation of osteoclast development(GO:2001205) |
| 0.0 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.0 |
0.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 |
0.3 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.1 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.0 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.2 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0046218 |
tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.1 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.0 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.0 |
0.0 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.0 |
0.0 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.0 |
0.0 |
GO:0021722 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.2 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.0 |
0.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.7 |
GO:0072413 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 |
0.1 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
